The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.

The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae.
复制标题

解决淋病奈瑟菌抗生素耐药性的前沿。

DOI:
10.1016/j.trsl.2020.02.002
复制
发表时间:
2020
期刊:
Translational research : the journal of laboratory and clinical medicine
影响因子:
--
通讯作者:
Grad,YonatanH
Grad,YonatanH
中科院分区:
--
文献类型:
--
作者:
Rubin,DanielHF;Ross,JonathanDC;Grad,YonatanH

文献摘要

参考文献

被引文献

相似文献

性传播感染淋病,由革兰氏阴性细菌淋病奈瑟氏菌引起,可引起尿道炎,宫颈炎和全身性疾病,以及其他表现。淋病的发病率沿着迅速上升,同时对包括一线治疗在内的多种药物的抗生素耐药性水平也在增加。耐药性的上升导致人们担心无法治愈的淋病会在全球范围内引起重大疾病。在这篇综述中,我们将描述正在采取的多种方法来减缓和控制这种耐药性的传播。首先,一些旧的药物已被重新利用,新的药物正在开发中,具有抗淋病奈瑟菌的活性。第二,疫苗的开发,长期以来的一个重要目标,正在推进。第三,新的诊断方法有望快速检测抗生素耐药性,并从经验性治疗转向定制治疗。部署这些新工具来应对抗生素耐药性的挑战将需要仔细考虑,以便为所有患者提供最佳护理,同时延长治疗方案的寿命。
The sexually transmitted infection gonorrhea, caused by the Gram-negative bacteriumNeisseria gonorrhoeae, can cause urethritis, cervicitis, and systemic disease, among other manifestations.N. gonorrhoeaehas rapidly rising incidence along with increasing levels of antibiotic resistance to a broad range of drugs including first-line treatments. The rise in resistance has led to fears of untreatable gonorrhea causing substantial disease globally. In this review, we will describe multiple approaches being undertaken to slow and control this spread of resistance. First, a number of old drugs have been repurposed and new drugs are being developed with activity againstNeisseria gonorrhoeae. Second, vaccine development, long an important goal, is advancing. Third, new diagnostics promise rapid detection of antibiotic resistance and a shift from empiric to tailored treatment. The deployment of these new tools for addressing the challenge of antibiotic resistance will require careful consideration to provide optimal care for all patients while extending the lifespan of treatment regimens.
DOI: 10.1097/olq.0000000000000693
发表时间: 2018-03
影响因子: 3.1
作者:
Mann LM;Kirkcaldy RD;Papp JR;Torrone EA
通讯作者: Torrone EA
一种新型的胸膜素抗菌化合物,其结合模式和选择性机制。
DOI: 10.1038/srep39004
发表时间: 2016-12-13
期刊: Scientific reports
影响因子: 4.6
作者:
Eyal Z;Matzov D;Krupkin M;Paukner S;Riedl R;Rozenberg H;Zimmerman E;Bashan A;Yonath A
通讯作者: Yonath A
索利霉素抑制金黄色葡萄球菌、肺炎链球菌和流感嗜血杆菌的蛋白质合成和核糖体生物发生
DOI: 10.1128/aac.02316-12
发表时间: 2013
影响因子: 4.9
作者:
Ward Rodgers;Ashley D. Frazier;W. S. Champney
通讯作者: W. S. Champney
DOI: 10.1177/0956462412472837
发表时间: 2013-02-01
影响因子: 1.4
作者:
Bignell, C.;Unemo, M.
通讯作者: Unemo, M.
DOI: 10.1136/bmjopen-2016-015447
发表时间: 2017-06-14
期刊: BMJ open
影响因子: 2.9
作者:
Turner KM;Christensen H;Adams EJ;McAdams D;Fifer H;McDonnell A;Woodford N
通讯作者: Woodford N